A phase I/II study of XELIRI plus bevacizumab as second-line chemotherapy for Japanese patients with metastatic colorectal cancer (bix study)

Oncologist

Volumn 19, Issue 11, 2014, Pages 1131-1132

  Hamamoto, Yasuo ^a   Yamaguchi, Tatsuro ^b   Nishina, Tomohiro ^c   Yamazaki, Kentaro ^d   Ura, Takashi ^e   Nakajima, Takako ^f   Goto, Ayumu ^g   Shimada, Ken ^h   Nakayama, Norisuke ⁱ   Sakamoto, Junichi ^j   Morita, Satoshi ^k   Yamada, Yasuhide ^l  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^d SHIZUOKA CANCER CENTER   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^h SHOWA UNIVERSITY NORTHERN YOKOHAMA HOSPITAL   (Japan)

ⁱ Kanagawa Cancer Center Hospital   (Japan)

^j Tokai Central Hospital of Japan Mutual Aid Association of Public School Teachers   (Japan)

^k KYOTO UNIVERSITY   (Japan)

^l NATIONAL CANCER CENTER HOSPITAL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; GLUCURONOSYLTRANSFERASE 1A1; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DEOXYCYTIDINE; FLUOROURACIL; MONOCLONAL ANTIBODY;

ADULT; AGED; ALOPECIA; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HAND FOOT SYNDROME; HUMAN; HYPERTENSION; LEUKOCYTE; MALE; METASTATIC COLORECTAL CANCER; MUCOSA INFLAMMATION; NAUSEA; NEUROPATHY; NEUTROPENIA; NEUTROPHIL COUNT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROGRESSION FREE SURVIVAL; TREATMENT RESPONSE; VOMITING; ANALOGS AND DERIVATIVES; ASIAN CONTINENTAL ANCESTRY GROUP; CHEMICALLY INDUCED; CLINICAL TRIAL; COLORECTAL NEOPLASMS; HAND-FOOT SYNDROME; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIAN CONTINENTAL ANCESTRY GROUP; BEVACIZUMAB; CAMPTOTHECIN; CAPECITABINE; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; DIARRHEA; FEMALE; FLUOROURACIL; HAND-FOOT SYNDROME; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908553442     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2014-0159     Document Type: Article

References (1)

1. Herbert I. Hurwitz, Niall C. Tebbutt, Fairooz Kabbinavar et al. Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials. The Oncologist 2013;18:1004-1012.